Loading…
This event has ended. Visit the official site or create your own event on Sched.
Learn the latest cancer care information to benefit your patients and earn up to 30 CNE contact hours! Register now at congress.ons.org.
Back To Schedule
Thursday, April 28 • 9:45am - 11:00am
American Association for Cancer Research/ONS Research Session: Epigenetics and Cancer

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Epigenetic mechanisms control gene expression without changing the DNA sequence itself. Recent research progress has shown that epigenetic pathways may provide new therapeutic avenues in cancer. It is now apparent that changes in epigenetic control of gene expression in cancer cells, and surrounding cells in the tumor microenvironment, play a fundamental role in driving tumor development, as well as response to chemotherapy and immune treatment. Come to understand epigenetic effector pathways involved in tumor biology and new approaches to target these pathways in cancer treatment.

Objectives

  1. Understand epigenetic pathways in cancer.
  2. Discuss current research in the area of epigenetics in cancer.
  3. Describe how epigenetic pathways can be targeted for new cancer therapies.

Speakers
avatar for Peter Jones, PhD, DSc

Peter Jones, PhD, DSc

Research Director and Chief Scientific Officer, Van Andel Research Institute
avatar for Wendy Henderson, CRNP, MSN, PhD

Wendy Henderson, CRNP, MSN, PhD

Investigator & Chief Digestive Disorders Unit Biobehavioral Branch, Division of Intramural Research National Institute of Nursing Research National Institutes of Health Department of Health and Human Services


Thursday April 28, 2016 9:45am - 11:00am CDT
221